Skip to main content

Want a detailed portfolio tracker?

Oncolytics Biotech (ONCY) P/E (2025 - 2026)

Oncolytics Biotech (ONCY) P/E from Mar 31, 2025 to Jun 3, 2026. The TTM Oncolytics Biotech (ONCY) P/E is -11.06. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Oncolytics Biotech (ONCY)

YearP/EChange
2026-11.06-29.58%
2025-15.70N/A

Comparison Oncolytics Biotech (ONCY) P/E with competitors

Oncolytics Biotech (ONCY) P/E is -11.06.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-100.92%
ENLVEnlivex Therapeutics Ltd0.15-101.36%
FGENFibroGen Inc0.24-102.17%
TRAWTraws Pharma Inc0.47-104.27%
FBIOFortress Biotech Inc0.71-106.38%
CHRSCoherus Biosciences Inc0.98-108.84%
ORMPOramed Pharmaceuticals Inc1.47-113.32%
AGENAgenus Inc2.05-118.52%
VIVSVivoSim Labs Inc2.54-122.93%
INVAInnoviva Inc3.19-128.83%
CRMDCorMedix Inc3.65-132.96%
ABEOAbeona Therapeutics Inc4.20-138.02%
VXRTVaxart Inc4.26-138.53%
CVACCureVac N.V.4.45-140.20%
SRPTSarepta Therapeutics Inc4.62-141.81%
GLPGGalapagos NV4.86-143.93%
RIGLRigel Pharmaceuticals4.92-144.48%
ZVRAZevra Therapeutics Inc4.97-144.97%
ABUSArbutus Biopharma Corp5.69-151.48%
CGENCompugen Ltd7.38-166.76%
AUPHAurinia Pharmaceuticals Inc9.25-183.65%
ACADAcadia Pharmaceuticals Inc9.59-186.69%
OMEROmeros Corporation9.88-189.36%
PLXProtalix BioTherapeutics Inc9.91-189.59%
SPROSpero Therapeutics Inc10.73-197.06%
ADMAAdma Biologics Inc11.33-202.45%
SVASinovac Biotech Ltd11.44-203.40%
TBPHTheravance Biopharma Inc11.78-206.48%
HRMYHarmony Biosciences Holdings Inc12.18-210.13%
TGTXTG Therapeutics Inc13.18-219.16%
INCYIncyte Corp13.38-221.00%
SABSSAB Biotherapeutics Inc14.06-227.11%
XOMAXOMA Corp14.95-235.13%
REGNRegeneron Pharmaceuticals Inc14.98-235.45%
PBYIPuma Biotechnology Inc15.05-236.08%
EXELExelixis Inc15.79-242.81%
NAGENiagen Bioscience Inc16.35-247.88%
CPRXCatalyst Pharmaceuticals Inc17.34-256.83%
MDXGMimedx Group Inc17.38-257.10%
ARGXArgen X SE23.07-308.61%
HALOHalozyme Therapeutics Inc23.20-309.77%
XOMAOXOMA Corp25.34-329.16%
VRTXVertex Pharmaceuticals Inc25.66-331.97%
XOMAPXOMA Corp25.67-332.10%
CTMXCytomX Therapeutics Inc25.70-332.35%
ASNDAscendis Pharma A/S26.35-338.28%
RPRXRoyalty Pharma plc - Class A27.50-348.60%
SLNOSoleno Therapeutics Inc29.02-362.35%
LGNDLigand Pharmaceuticals Inc - Class B30.19-372.94%
BMRNBiomarin Pharmaceutical Inc37.51-439.13%
APLSApellis Pharmaceuticals Inc39.02-452.82%
KRYSKrystal Biotech Inc39.70-458.93%
GMABGenmab40.20-463.51%
ONCBeiGene Ltd67.03-706.04%
TECHBio-Techne Corp68.59-720.21%
VCELVericel Corp80.63-829.02%
PHARPharming Group N.V.87.74-893.32%
ALNYAlnylam Pharmaceuticals Inc124.93-1229.61%
TLXTelix Pharmaceuticals Ltd139.89-1364.85%
CORTCorcept Therapeutics Inc158.39-1532.10%